Skip to main content

STERIS Value Stock - Dividend - Research Selection

Steris

ISIN: IE00BFY8C754 , WKN: A2PGLV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Virtus SGA International Growth Q4 2025 Portfolio Activity And Performance

2026-03-26
Fast Retailing was a top contributor during the quarter, driven by strong execution across its global operations.

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

2026-03-24
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Steris PLC stock underperforms Wednesday when compared to competitors

2026-03-18
Steris PLC stock underperforms Wednesday when compared to competitors

Steris PLC stock outperforms competitors on strong trading day

2026-03-16
Steris PLC stock outperforms competitors on strong trading day

A Look At STERIS (STE) Valuation After Recent Share Price Weakness

2026-03-16
What stands out about STERIS right now STERIS (STE) has drawn attention after a stretch of weaker share performance, with the stock down about 14% over the past month and 15% over the past 3 months, despite ongoing revenue and net income growth. See our latest analysis for STERIS. At a share price of $214.57, STERIS has a 1 day share price return of 1.05%, a 30 day share price return of 13.60%, and a 1 year total shareholder return of 4.87%. Recent weakness therefore contrasts with a still...

Is STERIS Stock Underperforming the Nasdaq?

2026-03-16
STERIS has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Dividend Champion, Contender, And Challenger Highlights: Week Of March 15

2026-03-13
Read the weekly roundup of dividend activity for Dividend Champions, Contenders & Challengers—dividend changes, upcoming ex-dividend dates and pay dates.

Steris PLC stock underperforms Thursday when compared to competitors

2026-03-12
Steris PLC stock underperforms Thursday when compared to competitors

3 Healthcare Stocks We Think Twice About

2026-03-11
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 4.1% over the past six months, almost identical to the S&P 500.

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

2026-03-06
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.